Helix Biopharm (HBP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 07-2024 | 04-2024 | 01-2024 | 10-2023 | 07-2023 | |
| Operating Expenses | 5,262 | 1,823 | 902 | 1,252 | 2,140 |
| Operating Income | -5,262 | -1,823 | -902 | -1,252 | -2,140 |
| Interest Expense | 1 | 2 | 22 | 3 | 2 |
| Other Income | -15 | -6 | 22 | 1 | -11 |
| Pre-tax Income | -5,278 | -1,831 | -902 | -1,254 | -2,153 |
| Net Income Continuous | -5,278 | -1,831 | -902 | -1,254 | -2,154 |
| Net Income | $-5,278 | $-1,831 | $-902 | $-1,254 | $-2,154 |
| EPS Basic Total Ops | -0.11 | -0.04 | -0.02 | -0.05 | -0.05 |
| EPS Basic Continuous Ops | -0.11 | -0.04 | -0.02 | -0.05 | -0.05 |
| EPS Diluted Total Ops | -0.11 | -0.04 | -0.02 | -0.05 | -0.05 |
| EPS Diluted Continuous Ops | -0.11 | -0.04 | -0.02 | -0.05 | -0.05 |
| EBITDA(a) | $-5,274 | $-1,825 | $-877 | $-1,247 | $-2,147 |